Brown Advisory Inc Regeneron Pharmaceuticals, Inc. Transaction History

Brown Advisory Inc

  • $75.5 Billion
  • Q4 2024

A detailed history of Brown Advisory Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 4,516 shares of REGN stock, worth $3.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,516
Previous 4,625 2.36%
Holding current value
$3.14 Million
Previous $4.86 Million 33.84%
% of portfolio
0.0%
Previous 0.01%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$701.85 - $1046.91 $76,501 - $114,113
-109 Reduced 2.36%
4,516 $3.22 Million
Q3 2024

Nov 13, 2024
SELL
$1024.09 - $1201.76 $37,891 - $44,465
-37 Reduced 0.79%
4,625 $4.86 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $11,481 - $13,925
13 Added 0.28%
4,662 $4.9 Million
Q1 2024

Apr 24, 2024
BUY
$902.69 - $993.35 $576,818 - $634,750
639 Added 15.94%
4,649 $4.47 Million
Q4 2023

Feb 08, 2024
SELL
$775.18 - $881.7 $53,487 - $60,837
-69 Reduced 1.69%
4,010 $3.52 Million
Q3 2023

Oct 24, 2023
SELL
$692.45 - $844.37 $692 - $844
-1 Reduced 0.02%
4,079 $3.36 Million
Q2 2023

Jul 31, 2023
SELL
$700.03 - $830.35 $163,106 - $193,471
-233 Reduced 5.4%
4,080 $2.93 Million
Q1 2023

May 08, 2023
SELL
$680.49 - $826.97 $170,802 - $207,569
-251 Reduced 5.5%
4,313 $3.54 Million
Q4 2022

Feb 13, 2023
SELL
$705.89 - $766.39 $51,529 - $55,946
-73 Reduced 1.57%
4,564 $3.29 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $961,399 - $1.21 Million
1,675 Added 56.55%
4,637 $3.2 Million
Q2 2022

Nov 14, 2022
BUY
$548.35 - $738.84 $210,018 - $282,975
383 Added 14.85%
2,962 $1.75 Million
Q2 2022

Sep 13, 2022
BUY
$548.35 - $738.84 $128,862 - $173,627
235 Added 7.43%
3,397 $2.01 Million
Q2 2022

Aug 02, 2022
BUY
$548.35 - $738.84 $291,722 - $393,062
532 Added 20.23%
3,162 $1.89 Million
Q1 2022

Nov 14, 2022
SELL
$595.12 - $698.43 $486,808 - $571,315
-818 Reduced 24.08%
2,579 $1.8 Million
Q1 2022

Sep 13, 2022
SELL
$595.12 - $698.43 $88,672 - $104,066
-149 Reduced 5.36%
2,630 $1.84 Million
Q1 2022

May 09, 2022
BUY
$595.12 - $698.43 $103,550 - $121,526
174 Added 6.68%
2,779 $1.9 Million
Q4 2021

Jan 27, 2022
BUY
$543.48 - $670.97 $107,609 - $132,852
198 Added 8.23%
2,605 $1.65 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $1,722 - $2,042
3 Added 0.12%
2,407 $1.46 Million
Q2 2021

Jul 29, 2021
BUY
$472.8 - $558.54 $53,899 - $63,673
114 Added 4.98%
2,404 $1.34 Million
Q1 2021

May 14, 2021
BUY
$446.73 - $548.2 $4,020 - $4,933
9 Added 0.39%
2,290 $1.08 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $215,235 - $273,591
-450 Reduced 16.48%
2,281 $1.1 Million
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $2,179 - $2,632
4 Added 0.15%
2,731 $1.53 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $16,772 - $21,893
34 Added 1.26%
2,727 $1.7 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $6,723 - $9,888
20 Added 0.75%
2,693 $1.31 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $34,814 - $47,816
127 Added 4.99%
2,673 $1 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $340,731 - $396,713
1,246 Added 95.85%
2,546 $707,000
Q2 2019

Aug 12, 2019
SELL
$299.6 - $414.82 $236,684 - $327,707
-790 Reduced 37.8%
1,300 $407,000
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $62,509 - $73,847
168 Added 8.74%
2,090 $859,000
Q4 2018

Feb 13, 2019
SELL
$335.82 - $403.04 $415,745 - $498,963
-1,238 Reduced 39.18%
1,922 $717,000
Q3 2018

Nov 13, 2018
SELL
$351.14 - $408.51 $3.04 Million - $3.54 Million
-8,663 Reduced 73.27%
3,160 $1.28 Million
Q2 2018

Aug 10, 2018
BUY
$284.6 - $344.99 $2.53 Million - $3.07 Million
8,898 Added 304.21%
11,823 $4.08 Million
Q1 2018

Jun 28, 2018
BUY
$315.82 - $393.78 $161,384 - $201,221
511 Added 21.17%
2,925 $1.01 Million
Q1 2018

May 14, 2018
SELL
$315.82 - $393.78 $132,960 - $165,781
-421 Reduced 14.85%
2,414 $831,000
Q4 2017

Feb 12, 2018
BUY
$358.63 - $469.95 $39,449 - $51,694
110 Added 4.04%
2,835 $1.07 Million
Q3 2017

Nov 13, 2017
SELL
$431.38 - $504.0 $9,058 - $10,584
-21 Reduced 0.76%
2,725 $1.22 Million
Q2 2017

Aug 14, 2017
BUY
N/A
2,746
2,746 $1.35 Million

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email